Fortress Biotech, Inc. - Jan 6, 2023 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Role: 10%+ Owner
Signature: /s/ Samuel Berry, General Counsel and Authorized Agent
Stock symbol: MBIO
Transactions as of: Jan 6, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/6/2023, 05:40 PM
Previous filing: Jan 6, 2023
Next filing: Apr 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MBIO	COMMON STOCK, PAR VALUE $0.0001	Award	$0	+2.81M	+14.16%	$0.00	22.6M	Jan 6, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MBIO	Class A Preferred Stock, par value $0.0001						250K	Jan 6, 2023	Common Stock	250K		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person is entitled to an annual dividend on its Class A Preferred Stock equal to 2.5% of the Issuer's fully diluted outstanding capitalization on December 31. These shares were granted by the Issuer to the Reporting Person for the 2022 annual dividend.
F2	The total number of shares beneficially owned by the Reporting Person includes those transactions as disclosed on the table filed herewith as Exhibit 99.
F3	Each share of the Issuer's Class A Preferred Stock is convertible at any time at the option of the Reporting Person into one share of the Issuer's Common Stock and has no expiration date.